Viewing Study NCT02693067


Ignite Creation Date: 2025-12-25 @ 12:46 AM
Ignite Modification Date: 2025-12-25 @ 10:59 PM
Study NCT ID: NCT02693067
Status: UNKNOWN
Last Update Posted: 2023-02-08
First Post: 2016-02-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver
Sponsor: Provectus Biopharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module